Phase II study of cisplatin and imatinib in advanced salivary adenoid cystic carcinoma.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  British Journal of Oral and Maxillofacial Surgery

• Publication date

  2011-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.bjoms.2010.09.013PMID 21071117
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Identification of c-kit gene mutations in primary adenoid cystic carcinoma of the salivary gland

  2009cited by this paper
• A phase II study of Imatinib for advanced adenoid cystic carcinoma of head and neck salivary glands.

  2007cited by this paper
• Salivary gland adenoid cystic carcinoma: a review of chemotherapy and molecular therapies.

  2006cited by this paper
• Synergistic effects of imatinib (STI 571) in combination with chemotherapeutic drugs in head and neck cancer

  2005cited by this paper
• Imatinib mesylate can induce objective response in progressing, highly expressing KIT adenoid cystic carcinoma of the salivary glands.

  2005cited by this paper
• Imatinib mesylate in patients with adenoid cystic cancers of the salivary glands expressing c-kit: a Princess Margaret Hospital phase II consortium study.

  2005cited by this paper
• Imatinib mesylate as treatment for adenoid cystic carcinoma of the salivary glands: Report of two successfully treated cases

  2004cited by this paper
• Expression of the c-kit protein is associated with certain subtypes of salivary gland carcinoma.

  2000cited by this paper
• Clinico-pathological and treatment-related factors influencing survival in parotid cancer

  1999cited by this paper
• Adenoid cystic carcinoma of the head and neck: predictors of morbidity and mortality.

  1999cited by this paper
• KIT protein expression and analysis of c-kit gene mutation in adenoid cystic carcinoma.

  1999cited by this paper
• Cisplatin and 5-fluorouracil for symptom control in advanced salivary adenoid cystic carcinoma.

  1997cited by this paper
• Distant metastasis in adenoid cystic carcinoma of salivary origin.

  1997cited by this paper
• Adenoid cystic carcinoma of the head and neck.

  1997cited by this paper
• Cisplatin, doxorubicin and cyclophosphamide in advanced salivary gland carcinoma. A phase II trial of 22 patients.

  1996cited by this paper
• Epirubicin in patients with advanced or recurrent adenoid cystic carcinoma of the head and neck: a phase II study of the EORTC Head and Neck Cancer Cooperative Group.

  1993cited by this paper
• Cisplatin‐based chemotherapy for neoplasms arising from salivary glands and contiguous structures in the head and neck

  1988cited by this paper
• Adenoid cystic carcinoma.

  1986cited by this paper
• Cisplatin therapy for adenoid cystic carcinoma.

  1981cited by this paper
• Chemotherapy for adenocystic carcinoma

  1980cited by this paper
• Adenoid cystic carcinoma: factors influencing survival.

  1979cited by this paper
• Adenoid cystic carcinoma of the head and neck

  1972cited by this paper
• Salivary gland tumours and their mucins.

  1959cited by this paper

• Systemic Therapy for Salivary Gland Cancers: A Review of Targeted and Chemotherapeutic Approaches

  2026cites this paper
• Current landscape and future directions of therapeutic approaches for adenoid cystic carcinoma of the salivary glands (Review)

  2025cites this paper
• Tumor classification of adenoid cystic carcinoma: systematic review and meta-analysis.

  2025cites this paper
• Advances in Targeted and Systemic Therapy for Salivary Gland Carcinomas: Current Options and Future Directions

  2025cites this paper
• Summary of Japanese clinical practice guidelines for head and neck cancer - 2025 update edited by the Japan Society for Head and Neck Cancer.

  2025cites this paper
• Treatment and Outcomes of Primary Tracheal Adenoid Cystic Carcinoma: A Systematic Review

  2025cites this paper
• Insights on Bmi-1 therapeutic targeting in head and neck cancers

  2025cites this paper
• Systemic treatments in recurrent or metastatic salivary gland cancer: a systematic review

  2024cites this paper
• The effectiveness of targeted therapy for recurrence or metastasis adenoid cystic carcinoma: a systematic review and meta-analysis

  2024cites this paper
• Diagnostic reliability of c-KIT (CD117) in salivary gland tumours – A systematic review and meta-analysis

  2024cites this paper
• Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review of the last decade

  2024cites this paper
• Translational Insights in the Landscape of Salivary Gland Cancers: Ready for a New Era?

  2024cites this paper
• Chemotherapy for Salivary Gland Malignant Carcinoma : Meta-analysis and Systemic Review

  2023cites this paper
• Therapeutic inhibition of Bmi-1 ablates chemoresistant cancer stem cells in adenoid cystic carcinoma.

  2023cites this paper
• Molecular Biology and Therapeutic Targets of Primitive Tracheal Tumors: Focus on Tumors Derived by Salivary Glands and Squamous Cell Carcinoma

  2023cites this paper
• A pilot study of volumetric and density tumor analysis of ACC patients treated with vorinostat in a phase II clinical trial

  2023cites this paper
• Actinomycosis of the right maxillary sinus mimicking the recurrence of adenoid cystic carcinoma – case presentation

  2022cites this paper
• 18F-fluorodeoxyglucose PET/Computed Tomography: Head and Neck Salivary Gland Tumors.

  2022cites this paper
• Targeted Therapy, Chemotherapy, Immunotherapy and Novel Treatment Options for Different Subtypes of Salivary Gland Cancer

  2022cites this paper
• A Contemporary Review of Molecular Therapeutic Targets for Adenoid Cystic Carcinoma

  2022cites this paper
• Treatment of Recurrent or Metastatic Adenoid Cystic Carcinoma

  2022cites this paper
• The Therapeutic Landscape of Salivary Gland Malignancies—Where Are We Now?

  2022cites this paper
• Panelsequenzierung in der Kopf-Hals-Onkologie am Beispiel von sinunasalen und Speicheldrüsenmalignomen

  2022cites this paper
• Cytotoxic effects of targeted agent alone or with chemotherapy in the treatment of adenoid cystic carcinoma: a preclinical study

  2022cites this paper
• Chemotherapy and Molecular Targeted Therapy

  2021cites this paper
• In vitro and in vivo evaluation of cytotoxic effect of targeted agents alone or in combination with chemotherapy for the treatment of adenoid cystic carcinoma

  2021cites this paper
• Systemic therapies for salivary gland adenoid cystic carcinoma.

  2021cites this paper
• Molecular Markers that Matter in Salivary Malignancy.

  2021cites this paper
• Management of Salivary Gland Malignancy: ASCO Guideline

  2021cites this paper
• Systemic Therapy for Salivary Gland Cancer

  2021cites this paper
• Prognosis and management of recurrent and/or metastatic head and neck adenoid cystic carcinoma.

  2021cites this paper
• Long-term outcomes of patients in different histological subtypes of primary nasopharyngeal adenocarcinoma: A single-center experience with 71 cases.

  2020cites this paper
• Variation in UK Deanery publication rates in the British Journal of Oral and Maxillofacial Surgery: where are the current 'hot spots'?

  2020cites this paper
• [Systemic treatments of metastatic or locally recurrent adenoid cystic carcinoma of the head and neck, a systematic review].

  2019cites this paper
• [Management of a tracheal adenoid cystic medico-surgical carcinoma].

  2019cites this paper
• Expression of EpCAM in adenoid cystic carcinoma.

  2018cites this paper
• Systemic therapy in metastatic salivary gland carcinomas: A pathology-driven paradigm?

  2017cites this paper
• Rak gruczołowo-torbielowaty regionu głowy i szyi – trudności diagnostyczne i metody leczenia

  2017cites this paper
• Applications of molecular testing in surgical pathology of the head and neck

  2017cites this paper
• New Developments in Salivary Gland Pathology: Clinically Useful Ancillary Testing and New Potentially Targetable Molecular Alterations.

  2017cites this paper
• A Phase II Study of Dovitinib in Patients with Recurrent or Metastatic Adenoid Cystic Carcinoma

  2017cites this paper
• Systemic therapy for recurrent or metastatic salivary gland malignancies

  2016cites this paper
• Association between clinical features, treatment, and recurrence rate of adenoid cystic carcinoma of the palate: a 10-year retrospective study.

  2016cites this paper
• Therapeutic Inhibition of the MDM2–p53 Interaction Prevents Recurrence of Adenoid Cystic Carcinomas

  2016cites this paper
• Diagnosis and Management of Malignant Salivary Gland Tumors of the Parotid Gland.

  2016cites this paper
• Carcinomas of the Head and Neck

  2015cites this paper
• Tracheal Cancer : A comprehensive Review

  2015cites this paper
• Diagnostic role of (18)F-FDG-PET or PET/CT in salivary gland tumors: A systematic review.

  2015cites this paper
• Vitamin D Analogs Potentiate the Antitumor Effect of Imatinib Mesylate in a Human A549 Lung Tumor Model

  2015cites this paper
• Airway compromise due to adenoid cystic carcinoma obstructing the distal trachea: a review of current management and clinical trials

  2015cites this paper
• Salivary Gland Cancers: Biology and Systemic Therapy.

  2015cites this paper
• Phase II trial of sorafenib in advanced salivary adenoid cystic carcinoma of the head and neck

  2015cites this paper
• Primary tracheal adenoid cystic carcinoma: adjuvant treatment outcome

  2015cites this paper
• Ongoing challenges in the treatment of adenoid cystic carcinoma of the head and neck

  2015cites this paper
• Adenoid cystic carcinoma of the head and neck - An update q

  2015cites this paper
• Adenoid cystic carcinoma: A review of recent advances, molecular targets, and clinical trials

  2015cites this paper
• Adenoid cystic carcinoma of the head and neck--An update.

  2015cites this paper
• Adenoid cystic carcinoma: current therapy and potential therapeutic advances based on genomic profiling

  2015cites this paper
• Phase II study of gefitinib in patients with advanced salivary gland cancers

  2015cites this paper
• Focused review of investigation, management and outcomes of salivary gland disease in specialty-specific journals.

  2014cites this paper
• Detection of predictive markers for therapeutic stratification of salivary glands tumors.

  2014cites this paper
• Recent trends in the management of minor salivary gland carcinoma

  2014cites this paper
• Adenoid Cystic Carcinoma

  2014cites this paper
• Molecular Markers and Chemotherapy for Advanced Salivary Cancer

  2014cites this paper
• Inhibition of autophagy augments chemotherapy in human salivary adenoid cystic carcinoma.

  2014cites this paper
• Metastatic Cancer of Cowper's Gland: A Rare Cancer Managed Successfully by Molecular Profiling

  2014cites this paper
• Validated RP-HPLC method for the simultaneous analysis of gemcitabine and LY-364947 in liposomal formulations.

  2013cites this paper
• INIBIDORES DAS TIROSINACINASES NA TERAPÊUTICA FARMACOLÓGICA

  2013cites this paper
• 75-jährige Patientin mit Pleuraerguss und gastralen Metastasen eines wenig differenzierten Karzinoms

  2013cites this paper
• Cetuximab and platinum-based chemoradio- or chemotherapy of patients with epidermal growth factor receptor expressing adenoid cystic carcinoma: a phase II trial

  2013cites this paper
• Immunohistochemical Analysis of Various Salivary Gland Carcinomas Focusing on the Possibility of Molecular-targeted and Hormonal Therapy

  2013cites this paper
• [A 75-year-old female patient with pleural effusion and gastric metastases of a poorly differentiated carcinoma].

  2013cites this paper
• The in-vitro antiproliferative effect of PRI-2191 and imatinib applied in combined treatment with cisplatin, idarubicin, or docetaxel on human leukemia cells

  2012cites this paper
• Primary Adenoid Cystic Carcinoma of the Lung

  2012cites this paper
• Activation of abl family kinases in solid tumors.

  2012cites this paper
• Full length articles published in BJOMS during 2010-11--an analysis by sub-specialty and study type.

  2012cites this paper
• A phase II study of sunitinib in recurrent and/or metastatic adenoid cystic carcinoma (ACC) of the salivary glands: current progress and challenges in evaluating molecularly targeted agents in ACC.

  2012cites this paper
• Imaging features of adenoid cystic carcinoma of the tongue with dedifferentiated components: a case report

  2012cites this paper
• Adenoid cystic carcinoma of the head and neck

  2012cites this paper
• Head and Neck Tumours

  2010cites this paper